Kaplan–Meier curves showed that, in the primary BC category, the cumulative 5-year disease-specific survival (DSS) rate was 95.6% for patients with lower levels of Rab27B and 64.0% for patients with higher levels of Rab27B expression (P < 0.01, Figure 2A). The gene discussed is RAB27B; the disease is breast cancer.